Synthesis, Characterization, and Cytocompatibility of Potential Cockle Shell Aragonite Nanocrystals for Osteoporosis Therapy and Hormonal Delivery

Overview

Journal Nanotechnol Sci Appl

Publisher Dove Medical Press

Specialty Biotechnology

Date 2017 Feb 9

PMID 28176933

Citations 6

Authors

Alhaji Zubair Jaji

Md Zuki Bin Abu Bakar

Rozi Mahmud

Mohamad Yusof Loqman

Mohamad Noor Mohamad Hezmee

Tijani Isa

Fu Wenliang

Nahidah Ibrahim Hammadi

Affiliations

Soon will be listed here.

Abstract

Calcium carbonate is a porous inorganic nanomaterial with huge potential in biomedical applications and controlled drug delivery. This study aimed at evaluating the physicochemical properties and in vitro efficacy and safety of cockle shell aragonite calcium carbonate nanocrystals (ANC) as a potential therapeutic and hormonal delivery vehicle for osteoporosis management. Free and human recombinant parathyroid hormone 1-34 (PTH 1-34)-loaded cockle shell aragonite calcium carbonate nanocrystals (PTH-ANC) were synthesized and evaluated using standard procedures. Transmission electron microscopy and field emission scanning electron microscopy results demonstrated highly homogenized spherical-shaped aragonite nanocrystals of 30±5 nm diameter. PTH-ANC had a zeta potential of -27.6±8.9 mV. The encapsulation efficiency of the formulation was found to be directly proportional to the concentrations of the drug fed. The X-ray diffraction patterns revealed strong crystallizations with no positional change of peaks before and after PTH-ANC synthesis. Fourier transform infrared spectroscopy demonstrated no detectable interactions between micron-sized aragonite and surfactant at molecular level. PTH-ANC formulation was stabilized at pH 7.5, enabling sustained slow release of PTH 1-34 for 168 h (1 week). A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cytocompatibility assay in Human Foetal Osteoblast Cell Line hFOB 1.19 showed that ANC can safely support osteoblast proliferation up to 48 h whereas PTH-ANC can safely support the proliferation at 72 h and beyond due to the sustained slow release of PTH 1-34. It was concluded that due to its biogenic nature, ANC is a cytocompatible antiosteoporotic agent. It doubles as a nanocarrier for the enhancement of efficacy and safety of the bone anabolic PTH 1-34. ANC is expected to reduce the cost, dosage, and dose frequency associated with the use of PTH 1-34 management of primary and secondary forms of osteoporosis.

Citing Articles

Curcumin-loaded cockle shell-derived calcium carbonate nanoparticles ameliorates lead-induced neurotoxicity in rats via attenuation of oxidative stress.

Mailafiya M, Abubakar K, Musa Chiroma S, Danmaigoro A, Zyoud T, Rahim E Food Sci Nutr. 2023; 11(5):2211-2231.

PMID: 37181299 PMC: 10171497. DOI: 10.1002/fsn3.3096.

Optimization of green and environmentally-benign synthesis of isoamyl acetate in the presence of ball-milled seashells by response surface methodology.

Fattahi A, Dekamin M, Clark J Sci Rep. 2023; 13(1):2803.

PMID: 36797437 PMC: 9935880. DOI: 10.1038/s41598-023-29568-y.

Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy.

Salave S, Rana D, Kumar H, Kommineni N, Benival D Pharmaceutics. 2022; 14(11).

PMID: 36365235 PMC: 9697760. DOI: 10.3390/pharmaceutics14112417.

Synthesis and Characterization of Gefitinib and Paclitaxel Mono and Dual Drug-Loaded Blood Cockle Shells ()-Derived Aragonite CaCO Nanoparticles.

Chemmalar S, Intan-Shameha A, Abdullah C, Ab Razak N, Mohamad Yusof L, Ajat M Nanomaterials (Basel). 2021; 11(8).

PMID: 34443820 PMC: 8398682. DOI: 10.3390/nano11081988.

Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.

Hamidu A, Mokrish A, Mansor R, Abdul Razak I, Danmaigoro A, Jaji A Int J Nanomedicine. 2019; 14:3615-3627.

PMID: 31190815 PMC: 6535674. DOI: 10.2147/IJN.S190830.

References

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

Eswaramoorthy R, Chang C, Wu S, Wang G, Chang J, Ho M . Sustained release of PTH(1-34) from PLGA microspheres suppresses osteoarthritis progression in rats. Acta Biomater. 2012; 8(6):2254-62. DOI: 10.1016/j.actbio.2012.03.015. View

Tran N, Webster T . Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles. Acta Biomater. 2010; 7(3):1298-306. DOI: 10.1016/j.actbio.2010.10.004. View

Dabbs D, Aksay I . Self-assembled ceramics produced by complex-fluid templation. Annu Rev Phys Chem. 2000; 51:601-22. DOI: 10.1146/annurev.physchem.51.1.601. View

Sugawara A, Ishii T, Kato T . Self-organized calcium carbonate with regular surface-relief structures. Angew Chem Int Ed Engl. 2003; 42(43):5299-303. DOI: 10.1002/anie.200351541. View

Wang , Sondi I , Matijevic . Preparation of Uniform Needle-Like Aragonite Particles by Homogeneous Precipitation. J Colloid Interface Sci. 1999; 218(2):545-553. DOI: 10.1006/jcis.1999.6463. View

Narayanan D, Anitha A, Jayakumar R, Nair S, Chennazhi K . Synthesis, characterization and preliminary in vitro evaluation of PTH 1-34 loaded chitosan nanoparticles for osteoporosis. J Biomed Nanotechnol. 2012; 8(1):98-106. DOI: 10.1166/jbn.2012.1367. View

Zhao Q, Han B, Wang Z, Gao C, Peng C, Shen J . Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studies. Nanomedicine. 2007; 3(1):63-74. DOI: 10.1016/j.nano.2006.11.007. View

Naka K, Huang S, Chujo Y . Formation of stable vaterite with poly(acrylic acid) by the delayed addition method. Langmuir. 2006; 22(18):7760-7. DOI: 10.1021/la060874k. View

10.

Cheng B, Cai W, Yu J . DNA-mediated morphosynthesis of calcium carbonate particles. J Colloid Interface Sci. 2010; 352(1):43-9. DOI: 10.1016/j.jcis.2010.08.050. View

11.

Choi S, Oh J, Choy J . Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem. 2009; 103(3):463-71. DOI: 10.1016/j.jinorgbio.2008.12.017. View

12.

Lotinun S, Sibonga J, Turner R . Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression. Endocrine. 2002; 17(1):29-36. DOI: 10.1385/ENDO:17:1:29. View

13.

Alexis F, Pridgen E, Molnar L, Farokhzad O . Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008; 5(4):505-15. PMC: 2663893. DOI: 10.1021/mp800051m. View

14.

McLeod M, Gale W, Roberts C . Metallic nanoparticle production utilizing a supercritical carbon dioxide flow process. Langmuir. 2004; 20(17):7078-82. DOI: 10.1021/la0493262. View

15.

Wang Y, Moo Y, Chen C, Gunawan P, Xu R . Fast precipitation of uniform CaCO3 nanospheres and their transformation to hollow hydroxyapatite nanospheres. J Colloid Interface Sci. 2010; 352(2):393-400. DOI: 10.1016/j.jcis.2010.08.060. View

16.

Jilka R . Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone. 2007; 40(6):1434-46. PMC: 1995599. DOI: 10.1016/j.bone.2007.03.017. View

17.

Kamba A, Zakaria Z . Osteoblasts growth behaviour on bio-based calcium carbonate aragonite nanocrystal. Biomed Res Int. 2014; 2014:215097. PMC: 3964785. DOI: 10.1155/2014/215097. View

18.

Hu Z, Niu H, Yang X, Li H, Sang G, Li B . Recombinant human parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats. Int J Pharm. 2006; 317(2):144-54. DOI: 10.1016/j.ijpharm.2006.03.005. View

19.

Holroyd C, Cooper C, Dennison E . Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008; 22(5):671-85. DOI: 10.1016/j.beem.2008.06.001. View

20.

Kamel H . Postmenopausal osteoporosis: etiology, current diagnostic strategies, and nonprescription interventions. J Manag Care Pharm. 2007; 12(6 Suppl A):S4-9. PMC: 10437637. DOI: 10.18553/jmcp.2006.12.S6-A.S4. View